(Q33330720)

English

Cisplatin-epirubicin-paclitaxel weekly administration in advanced breast cancer: a phase I study of the Southern Italy Cooperative Oncology Group

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

25 July 2017

Cisplatin-epirubicin-paclitaxel weekly administration in advanced breast cancer: a phase I study of the Southern Italy Cooperative Oncology Group (English)

1 reference

Europe PubMed Central

25 July 2017

0 references

author name string

Frasci G

1

1 reference

Europe PubMed Central

25 July 2017

D'Aiuto G

2

1 reference

Europe PubMed Central

25 July 2017

Comella P

3

1 reference

Europe PubMed Central

25 July 2017

Apicella A

4

1 reference

Europe PubMed Central

25 July 2017

Thomas R

5

1 reference

Europe PubMed Central

25 July 2017

Capasso I

6

1 reference

Europe PubMed Central

25 July 2017

Di Bonito M

7

1 reference

Europe PubMed Central

25 July 2017

Cartenì G

8

1 reference

Europe PubMed Central

25 July 2017

Biglietto M

9

1 reference

Europe PubMed Central

25 July 2017

De Lucia L

10

1 reference

Europe PubMed Central

25 July 2017

Maiorino L

11

1 reference

Europe PubMed Central

25 July 2017

Piccolo S

12

1 reference

Europe PubMed Central

25 July 2017

Bianchi U

13

1 reference

Europe PubMed Central

25 July 2017

D'Aniello R

14

1 reference

Europe PubMed Central

25 July 2017

Lapenta L

15

1 reference

Europe PubMed Central

25 July 2017

Comella G

16

1 reference

Europe PubMed Central

25 July 2017

language of work or name

0 references

publication date

1 August 1999

1 reference

Europe PubMed Central

25 July 2017

Breast Cancer Research and Treatment

1 reference

Europe PubMed Central

25 July 2017

56

1 reference

Europe PubMed Central

25 July 2017

3

1 reference

Europe PubMed Central

25 July 2017

239-252

1 reference

Europe PubMed Central

25 July 2017

https://scigraph.springernature.com/pub.10.1023/a:1006263226099

0 references

Chemotherapy and survival in advanced breast cancer: the inclusion of doxorubicin in Cooper type regimens

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006263226099

21 January 2018

Dose-dense therapy with weekly 1-hour paclitaxel infusions in the treatment of metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006263226099

21 January 2018

Paclitaxel by 3-hour infusion in combination with bolus doxorubicin in women with untreated metastatic breast cancer: high antitumor efficacy and cardiac effects in a dose-finding and sequence-finding study.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006263226099

21 January 2018

Cisplatin as first-line therapy for metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006263226099

21 January 2018

Cisplatin and its analogues in the treatment of advanced breast cancer: a review

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006263226099

21 January 2018

Acquired cisplatin resistance in human ovarian cancer cells is associated with enhanced repair of cisplatin-DNA lesions and reduced drug accumulation

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006263226099

21 January 2018

Weekly paclitaxel-cisplatin administration with G-CSF support in advanced breast cancer. A phase II study

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006263226099

21 January 2018

Reporting results of cancer treatment

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006263226099

21 January 2018

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006263226099

21 January 2018

Long-term follow-up of patients with complete remission following combination chemotherapy for metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006263226099

7 January 2021

based on heuristic

inferred from DOI database lookup

Paclitaxel as second and subsequent therapy for metastatic breast cancer: activity independent of prior anthracycline response

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006263226099

7 January 2021

based on heuristic

inferred from DOI database lookup

Docetaxel is a major cytotoxic drug for the treatment of advanced breast cancer: a phase II trial of the Clinical Screening Cooperative Group of the European Organization for Research and Treatment of Cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006263226099

7 January 2021

based on heuristic

inferred from DOI database lookup

Dose-finding study and pharmacokinetics of epirubicin and paclitaxel over 3 hours: a regimen with high activity and low cardiotoxicity in advanced breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006263226099

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase I/II trial of biweekly paclitaxel and cisplatin in the treatment of metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006263226099

7 January 2021

based on heuristic

inferred from DOI database lookup

Nonlinear pharmacokinetics and metabolism of paclitaxel and its pharmacokinetic/pharmacodynamic relationships in humans

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006263226099

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of preoperative chemotherapy on local-regional disease in women with operable breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-18

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006263226099

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1023/A:1006263226099

1 reference

Europe PubMed Central

25 July 2017

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

25 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33330720&oldid=1509344267"